Clinical Trial Detail

NCT ID NCT03115801
Title A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

renal cell carcinoma

transitional cell carcinoma

Therapies

Atezolizumab

Nivolumab

Age Groups: adult senior

No variant requirements are available.